The Food and Drug Administration’s Division of Northern Border Imports recently sent a notice to customs brokers concerning an increase in truck traffic carrying FDA-regulated commodities into the U.S. from Canada without stopping for FDA examination.

The notice emphasizes that it is the responsibility of each importing party associated with an entry (the broker and carrier) to become familiar with and follow established procedures for importing FDA-regulated goods. The FDA states that doing so will expedite its final admissibility decisions and prevent unnecessary and costly delays, including the need to return the entry for physical examination.

The FDA therefore encourages brokers and carriers to work together to ensure that complete and accurate electronic entry data is submitted, appropriate documentation is timely submitted, and cargo is made available for FDA examination. For entries crossing during the FDA’s hours of operation, carriers are strongly encouraged to report to the FDA for exam and clearance, which will expedite the final admissibility decision.

Copyright © 2021 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.